Stock Report

Suven Pharma consolidated Q3FY22 PAT Jumps to Rs. 160.06 crores

Posted On : 2022-02-08 14:25:28( TIMEZONE : IST )

Suven Pharmaceuticals Limited has reported Consolidated financial results for the period ended December 31, 2021.

Financial Results (Q3 FY2022) - QoQ Comparison

The company has reported total income of Rs. 456.2704 crores during the period ended December 31, 2021 as compared to Rs. 306.0294 crores during the period ended September 30, 2021.

The company has posted net profit / (loss) of Rs. 160.0690 crores for the period ended December 31, 2021 as against net profit / (loss) of Rs. 96.9848 crores for the period ended September 30, 2021.

The company has reported EPS of Rs. 6.29 for the period ended December 31, 2021 as compared to Rs. 3.81 for the period ended September 30, 2021.

Financials	Q3 FY2022	Q2 FY2022	% Change
Total Income	₹ 456.2704 crs	₹306.0294 crs	49.09%
Net Profit	₹160.0690 crs	₹96.9848 crs	65.05%
EPS	₹6.29	₹3.81	65.09%

Financial Results (Q3 FY2022) - YoY Comparison

The company has reported total income of Rs. 456.2704 crores during the period ended December 31, 2021 as compared to Rs.279.7761 crores during the period ended December 31, 2020.

The company has posted net profit / (loss) of Rs.160.0690 crores for the period ended December 31, 2021 as against net profit / (loss) of Rs.113.6253 crores for the period ended December 31, 2020.

The company has reported EPS of Rs.6.29 for the period ended December 31, 2021 as compared to Rs.4.46 for the period ended December 31, 2020.

Financials	Q3 FY2022	Q3 FY2021	% Change
Total Income	₹ 456.2704 crs	₹279.7761 crs	63.08%
Net Profit	₹160.0690 crs	₹113.6253 crs	40.87%
EPS	₹6.29	₹4.46	41.03%

Financial Results (9 Months Ended FY2022) - YoY Comparison

The company has reported total income of Rs.1031.8840 crores during the 9 Months period ended December 31, 2021 as compared to Rs.761.4925 crores during the 9 Months period ended December 31, 2020.

The company has posted net profit / (loss) of Rs.362.1369 crores for the 9 Months period ended December 31, 2021 as against net profit / (loss) of Rs.279.2259 crores for the 9 Months period ended December 31, 2020.

The company has reported EPS of Rs.14.23 for the 9 Months period ended December 31, 2021 as compared to Rs.10.97 for the 9 Months period ended December 31, 2020.

Financials	9 Months Ended FY2022	9 Months Ended FY2021	% Change
Total Income	₹1031.8840 crs	₹761.4925 crs	35.51%
Net Profit	₹362.1369 crs	₹279.2259 crs	29.69%
EPS	₹14.23	₹10.97	29.72%

Shares of Suven Pharmaceuticals Limited was last trading in BSE at Rs. 558.50 as compared to the previous close of Rs. 557.75. The total number of shares traded during the day was 9198 in over 535 trades.

The stock hit an intraday high of Rs. 565.35 and intraday low of 554.60. The net turnover during the day was Rs. 5149744.00.